These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31190920)

  • 1. Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis.
    Su HC; Hua YM; Feng IJ; Wu HC
    Infect Drug Resist; 2019; 12():1311-1324. PubMed ID: 31190920
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.
    Wang J; Zhou M; Xu JY; Zhou RF; Chen B; Wan Y
    JAMA Netw Open; 2020 Oct; 3(10):e2017652. PubMed ID: 33030550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD; Kourbeti IS; Mylonakis E
    Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
    J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal agents in preventing oral candidiasis in clinical oncology: A network meta-analysis.
    Shen Loo Y; Yee Wong T; Veettil SK; Se Wong P; Gopinath D; Mooi Ching S; Kunnath Menon R
    Oral Dis; 2021 Oct; 27(7):1631-1643. PubMed ID: 32762108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
    Xu SX; Shen JL; Tang XF; Feng B; Xu HQ
    Eur Rev Med Pharmacol Sci; 2016; 20(2):381-90. PubMed ID: 26875911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer antifungal agents for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
    Xu SX; Shen JL; Tang XF; Feng B
    Transplant Proc; 2013; 45(1):407-14. PubMed ID: 23375330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
    Bow EJ; Vanness DJ; Slavin M; Cordonnier C; Cornely OA; Marks DI; Pagliuca A; Solano C; Cragin L; Shaul AJ; Sorensen S; Chambers R; Kantecki M; Weinstein D; Schlamm H
    BMC Infect Dis; 2015 Mar; 15():128. PubMed ID: 25887385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Efficacy of Antifungal Agents Used in the Treatment of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis.
    Rajadurai SG; Maharajan MK; Veettil SK; Gopinath D
    J Fungi (Basel); 2021 Aug; 7(8):. PubMed ID: 34436176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compare the efficacy of antifungal agents as primary therapy for invasive aspergillosis: a network meta-analysis.
    Liu A; Xiong L; Wang L; Zhuang H; Gan X; Zou M; Wang X
    BMC Infect Dis; 2024 Jun; 24(1):581. PubMed ID: 38867163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants.
    Grau S; Solano C; García-Vidal C; Jarque I; Barrueta JA; Peral C; Rodríguez I; Rubio-Rodríguez D; Rubio-Terrés C
    J Health Econ Outcomes Res; 2016; 3(2):153-161. PubMed ID: 35619591
    [No Abstract]   [Full Text] [Related]  

  • 12. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide.
    El-Cheikh J; Crocchiolo R; Vai A; Furst S; Bramanti S; Sarina B; Granata A; Faucher C; Mohty B; Harbi S; Bouabdallah R; Vey N; Santoro A; Chabannon C; Castagna L; Blaise D
    Mediterr J Hematol Infect Dis; 2015; 7(1):e2015048. PubMed ID: 26401237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review.
    Pechlivanoglou P; Le HH; Daenen S; Snowden JA; Postma MJ
    J Antimicrob Chemother; 2014 Jan; 69(1):1-11. PubMed ID: 23975736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.
    Tamura K; Drew R
    Drugs Today (Barc); 2008 Jul; 44(7):515-30. PubMed ID: 18806902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials.
    Lee CH; Lin C; Ho CL; Lin JC
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive Fungal Infections While on Voriconazole, Liposomal Amphotericin B, or Micafungin for Antifungal Prophylaxis in Pediatric Stem Cell Transplant Patients.
    Bui A; Nguyen V; Hsu C; Hyde B; Simms-Waldrip T
    J Pediatr Pharmacol Ther; 2019; 24(3):220-226. PubMed ID: 31093021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
    Solano C; Slavin M; Shaul AJ; Marks DI; Cordonnier C; Cornely OA; Pagliuca A; Cragin L; Jarque I; Garcia-Vidal C; Sorensen S; Vanness DJ; Charbonneau C; Barrueta JA; Peral C; De Salas-Cansado M; Bow EJ
    Mycoses; 2017 Feb; 60(2):79-88. PubMed ID: 27562016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term antifungal prophylaxis in high-risk hematopoietic stem cell transplant recipients.
    Bow EJ
    Med Mycol; 2005 May; 43 Suppl 1():S277-87. PubMed ID: 16110821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta-analysis.
    Sehgal IS; Dhooria S; Prasad KT; Muthu V; Aggarwal AN; Chakrabarti A; Agarwal R
    Mycoses; 2021 Sep; 64(9):1053-1061. PubMed ID: 34031920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.